Genzyme Corporation

Sanofi unit Genzyme in alliance with Alnylam Pharmaceuticals to develop RNAi therapeutics

Sanofi-Aventis extends Genzyme offer, terms unchanged

Genzyme to sell diagnostics business to Japan's Sekisui Chemical for $265 million

Genzyme to sell genetic testing business to LabCorp for $925 million

Sanofi Aventis reportedly raises offer to $71 per share

Genzyme board rejects Sanofi-Aventis $18.5-billion takeover offer

Sanofi-Aventis reveals $18.5-billion offer for Genzyme

Genzyme begins takeover talks with Sanofi-Aventis

Glaxo follows Sanofi-Aventis to biotech major Genzyme

Sanofi-Aventis targets troubled Genzyme Corp for takeover

Genzyme starts shipments of drugs for two rare disorders

Genzyme confident of restarting virus-hit Allston plant by August

Bayer HealthCare and Genzyme finalise strategic alliance agreement

Nicholas Piramal seals an in-licensing agreement with Genzyme Corporation for the Indian market